Sign up


Match Document Document Title
5935988 Tolerability of pharmaceutically active β-amino acids  
The present invention relates to mixtures of α-amino acids and/or derivatives thereof and cyclopentane-β-amino acids and/or derivatives thereof, dipeptides of the abovementioned α-amino acids an...
5935994 Nutritionally balanced dermal composition and method  
A composition and method for enhancing the appearance of the skin, the composition containing a mixture of essential amino acids, a penetrant, a neucleotide, vitamin C and vitamin E.
5932229 Oxa diacids and related compounds for treating skin conditions  
Described are the use of compounds of Formula (I), depicted below, as active principals for treating skin conditions; compositions containing these compounds; and methods of treating skin...
5922361 Folic acid enriched dietary supplement compositions for self-regulating stress-reduction  
A food supplement compositions combining suitable precursor substrates with folic acid, whereby methionine is produced in sufficient quantity to produce a sufficient quantity of met-enkephalin...
5919823 Treatment of secondary movement disorders using large neutral amino acids  
The present invention relates to a method of remitting or attenuating the symptoms of movement disorders which can be secondary to treatment of psychiatric disorders with antipsychotic drugs mainly...
5916912 Dietary composition for enhancing metabolism and alleviating oxidative stress  
The metabolic rate of aged cells of a mammalian host is enhanced without a concomitant increase in metabolic production of reactive oxygen species by orally administering to the host an effective...
5916573 Topical treatment of the skin with a grapeseed oil composition  
A grapeseed oil composition for topical application to the skin comprising: a) about 1 to about 99% by weight of grapeseed oil; b) at least one hydrating agent; and c) water. Hydrating agents...
5916922 Phenyl glyoxamides as SPLA2 inhibitors  
A class of novel phenyl glyoxamides is disclosed together with the use of such compounds for inhibiting sPLA2 mediated release of fatty acids for treatment of conditions such as septic shock.
5916920 3-substituted Bicyclo 3.1.0!hexane-6-carboxylic acids  
Compounds of the formula ##STR1## in which X represents a bond, S, O or NRa ; and R is as defined in the specification are useful as modulators of metabotropic glutamate receptor function.
5916921 Therapeutic agents for liver regeneration  
A therapeutic agent for liver regeneration which contains valine as an active ingredient is disclosed that is effective against hepatopathy in hepatitis, fatty liver and drug-induced liver...
5914135 Liquid antacid compositions  
Calcium carbonate liquid antacid compositions containing one or more pH adjusting agents to maintain the pH above 9.0, preferably above 9.5. The resultant antacid liquid possesses superior...
5912248 Excitatory amino acid receptor antagonists  
Compounds of the formula ##STR1## in which X represents a bond, S, SO or SO2 ; and R is as defined in the specification are useful as modulators of metabotropic glutamate receptor function.
5908863 Geminal carboxylic acids and esters thereof pharmaceutical formulations containing them useful in the treatment of bone dysmetabolism  
Compounds of formula I: ##STR1## wherein Ra, Rb, Φ, B and R are as defined in the disclosure, have antagonistic activity on osteoclast hyper-reactivity.
5906985 Pharmaceutical compounds  
Pharmaceutical compounds of the formula ##STR1## in which n is 0, 1 or 2 and m is 1 or 2, R1 is hydrogen, C1-10 alkyl, C2-10 alkenyl, C2-10 alkynyl, phenyl, naphthyl, C1-10 alkyl-phenyl, C2-10...
5888518 Method for preventing and treating coccidiosis  
A method for preventing and treating parasitic infections in animals by administering a lysine analog, such as EACA, to the animals on a continuous basis. In the preferred embodiment, the method of...
5889040 Composition for increasing protein concentration in a mammal  
The present invention is based in part upon the discovery that the use of pyruvate in enteral formulations, in combination with an anabolic protein composition, produces a synergistic effect in...
5889055 L-carnitine and acetyl-L-carnitine combined for prevention and treatment of syndromes related to diseases of energy metabolism  
A combination can be of L-carnitine and acetyl-L-carnitine administered orally or as parenteral injection in domesticated animals, especially pet animals, and humans for prevention or treatment of...
5886022 Substituted cycloalkanecarboxylic acid derivatives as matrix metalloprotease inhibitors  
Inhibitors for matrix metalloproteases, pharmaceutical compositions containing them, and a process for using them to treat a variety of physiological conditions. The compounds of the invention have...
5880154 Polymeric adamantane analogues  
Novel polymeric adamantane analogues are disclosed comprising adamantane linked by means of a spacer group to an anionogenic polymeric carrier which creates a membranotropic composition. The...
5869067 Bi-aromatic compounds and pharmaceutical and cosmetic compositions  
The present invention relates to new aromatic compounds, to their preparation and to their use in human and veterinary medicine and in cosmetic compositions.
5866591 Stable formulations of remifentanil  
Stable formulations of 3- 4-methoxycarbonyl-4- (1 -oxopropyl)phenylamino!-1-piperidine!propanoic acid, methyl ester, generally referred to as remifentanil, are disclosed. In particular, stabilized...
RE36080 Method for augmenting fetal hemoglobin  
A method is provided for inhibiting the γ to β-globin switching in subjects afflicted with β-globin disorders. The method is particularly adapted for ameliorating the clinical symptoms of sickle ce...
5866537 Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids  
A pharmaceutical or dietetic composition or both a pharmaceutical and dietetic composition having antioxidant activity contains carnosine or derivatives of carnosine and leucine, isoleucine and...
5863563 Treatment of pulmonary conditions associated with insufficient secretion of surfactant  
Methods and compositions for the treatment of the symptoms of a patient who has a pulmonary condition associated with an inhibition of surfactant secretion by type II alveolar cells are described....
5861431 Incontinence treatment  
The present invention provides a method of treating incontinence in a patient that has a bladder and a urethra. The urethra forms a lumen for draining the bladder. The method comprises the steps of...
5861434 Compositions containing L-carnitine or an acyl L-carnitine in combination with an ace-inhibitor for the treatment of cardiovascular disorders and a method for treating cardiovascular disorders  
Compositions containing (a) L-carnitine, an acyl L-carnitine, or a pharmacologically acceptable salt thereof in combination with (b) an ACE-inhibitor are useful for treating cardiovascular...
5861435 Method for preventing settlement of aquatic fouling organisms  
A method for preventing settlement of aquatic fouling organisms on surface of an aquatic structure without environmental hazard is provided. The method is based upon absolutely novel concept to...
5851537 Topical application of α-DFMO for preventing skin cancer  
A salve includes a water-miscible, hydrophilic cream vehicle, 1-22% by weight a-DFMO, and no absorption enhancer. The salve is preferably contained in an ointment tube permanently sealed at one end...
5852009 Compositions, including pharmaceutical compositions, for inhibiting the advanced glycosylation of proteins, and therapeutic methods based thereon  
The present invention relates to compositions and methods for inhibiting protein aging. Accordingly, a composition is disclosed which comprises an agent or compound capable of inhibiting the...
5847002 Compositions, for inhibition, control and regression of angiogenesis, containing hyaluronic acid and NSAID  
The use of:(a) a non-steroidal anti-inflammatory agent,and(b) hyaluronic acid and/or salts thereof and/or homologues, analogues, derivatives, complexes, esters, fragments, and subunits of...
5843997 Excitatory amino acid receptor antagonists  
The present invention provides novel compounds that affect excitatory amino acid receptors and are useful in the treatment of neurological disorders. This invention also provides synthetic methods...
5834516 Meadowfoam betaines in personal care applications  
The present invention deals with the composition of matter and the utilization of certain novel meadowfoam based betaine compounds. These materials are useful in personal care applications.
5834517 Meadowfoam sulfosuccinates in personal care applications  
The present invention deals with a process for cleaning and conditioning hair and skin which comprises the contacting of hair or skin woth an effective concentration of certain novel meadowfoam...
5830919 Method to protect plants from fungal infection  
A method for protecting a crop against fungal diseases by inducing local and systemic resistance of the crop comprising applying to the crop or its locus a composition containing an effective...
5827886 Composition for relief of arthritis-induced symptoms  
A composition and method of using it for ameliorating inflammatory reactions and painful and other symptoms of the diseases of arthritis, lumbago, low back pain, myalgias and neuralgias. The...
5827820 Aqueous peritoneal dialysis solution  
The subject matter of this invention concerns an aqueous peritoneal dialysis solution which is obtained immediately prior to administration from two individual solutions, the first of which...
5824708 Virucidal substances  
The process of reducing the count of a virus by contacting the virus with (1) the reaction product of a) N-substituted propylenediamines corresponding to formula I: R1 --NH--CH2 --CH2 --CH2 --NH2...
5817329 Nutritional supplement for increased muscle size and strength for body builders  
The present invention relates to the method and composition for use of diet supplements by athletes and bodybuilders. A first supplement comprising, the amino acid acetyl-L-Carnitine, in...
5817621 External remedy possessing trophoprotective effect  
A dermatological composition for external use comprising a lipid ointment base, vitamin A, a salicylic acid or a derivative thereof, D-camphor, a biogenic GABAergic substance, a biogenic...
5817695 Nutritional product with high fat, low carbohydrate and amino acid imbalance  
A nutritional product is provided for cancer patients comprising, as per caloric requirement, a low concentration of carbohydrate, a high concentration of fat and an imbalance of amino acids...
5798363 Use for tachykinin antagonists to treat emesis  
The present invention relates to the use of tachykinin antagonists, including substance P antagonists and other neurokinin antagonists, in the treatment of emesis. Also described are novel...
5798371 Pharmaceutical composition endowed with an antialcoholic and nootropic effect  
A pharmaceutical composition having an antialcoholic and nootropic effect which is administered sublingually. The active ingredients of the composition are the amino acid L-threonine or a...
5792796 Methods for treating anxiety and panic  
The instant invention is novel uses of known cyclic amino acids. Such compounds as gabapentin are useful in the treatment of anxiety and in the treatment and/or prevention of panic attacks.
5789443 Method for treating flushing associated with menopause  
A method for treating flushing as a symptom of menopause is disclosed. Specifically, the method comprises administering to a patient in need thereof an effective amount of leucine, or leucine in...
5788958 Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders  
The present invention is directed to the use of an inhibitor of NO activity, such as a nitric oxide scavenger or an NO synthase inhibitor, as an antitumor therapy to reduce tumor blood flow and...
5783593 Inhibitors of squalene synthetase and protein farnesyltransferase  
The present invention provides a compound of the formula ##STR1## which inhibit squalene synthetase and cholesterol biosynthesis and are useful in the treatment of e.g., hyperlipidaemia,...
5776503 Amino acid solutions for treatment of peritoneal dialysis patients  
The present invention provides a dialysis solution that contains amino acids for treating and/or preventing malnutrition in a peritoneal dialysis patient. The amino acid composition is optimized to...
5770619 Method of activating photosensitive agents  
A method of administering photodynamic therapy begins with administering to an animal an effective amount of a photosensitizing agent which is less than about one half of the usual clinical dose...
5770622 Method of preserving materials using 4-methylene-2-amino-cyclopentane-1-carboxylic acids  
The invention relates to cyclopentane- and -pentene-β-amino acids, processes for their preparation and their use as medicaments, and to prevent contamination of materials such as wood and leather.
5767091 Analgesic effect enhancing preparations  
The present invention provides an analgesic effect enhancing preparation capable of enhancement of the effect of analgesics, the preparation comprising as an active ingredient the following amino...